- Andreas C. Dracopoulos Director
Robert Henry Levi and Ryda Hecht Levi Professor of Bioethics and Public Policy
Berman Institute of Bioethics - Professor
Dept. of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health
Jeffrey Kahn, PhD, MPH, is the Andreas C. Dracopoulos Director of the Johns Hopkins Berman Institute of Bioethics, a position he assumed in July 2016, and was re-appointed to for a second five-year term in 2023. From 2011, he has been the inaugural Robert Henry Levi and Ryda Hecht Levi Professor of Bioethics and Public Policy. He is also Professor in the Dept. of Health Policy and Management of the Johns Hopkins Bloomberg School of Public Health. He works in a variety of areas of bioethics, exploring the intersection of ethics and health/science policy, including human and animal research ethics, public health, and ethical issues in emerging biomedical technologies.
Research Interests
- The intersection of ethics and health/science policy
- Human and animal research ethics
- Public health
- Ethical issues in emerging biomedical technologies.
Education
- PhD, Georgetown University
- MPH, Johns Hopkins Bloomberg School of Public Health
- BA, University of California, Los Angeles
Recent Publications
- Hutler B, Blasimme A, Gur-Arie R et al. incl.Kahn J. “Assessing the Governance of Digital Contact Tracing in Response to COVID-19: Results of a Multi-National Study.” Journal of Law, Medicine, and Ethics 50(4): 791-804; 2022.
- Rieder TN, Hutchinson LA, Kahn JP. “Why the World Needs Bioethics Communication.” Perspectives in Biology and Medicine 65(4): 629-636; 2022.
- Hughes MT, Auwaerter PG, Ehmann MR, Garibaldi BT, Golden SH, Lorigiano T, O’Conor KJ, Kachalia A, Kahn J. “The importance of offering vaccine choice in the fight against COVID-19.” Proc Natl Acad Sci USA 2021; 118:e2117185118.
- Gerber, JE, Brewer, J, Rupali, JL, et al. incl. Kahn, JP, “Vaccinomics: a cross-sectional survey of public values.” Human Vaccines & Immunotherapeutics, June 2021, DOI: 10.1080/21645515.2021.1911217
- Hughes, MT, Kahn, JP, Kachalia, A, “Who Goes First? Government Leaders and Prioritization of SARS-CoV-2 Vaccines.” The New England Journal of Medicine, January 2021. DOI: 10.1056/NEJMpv2036128.
- Ferretti, A, Ienca, M, Sheehan, M, et al incl. Kahn, JP, “Ethics review of big data research: What should stay and what should be reformed?” BMC Medical Ethics 22 (51); 2021. DOI: https://doi.org/10.1186/s12910-021-00616-4.
- Geller, G, Duggal, P, Thio, CL, et al incl. Kahn JP, “Genomics in the Era of COVID-19: Ethical Implications for Clinical Practice and Public Health.” Genome Medicine 12 (95); 2020. DOI: https://doi.org/10.1186/s13073-020-00792-9.
- Kahn, JP, Henry, LM, Mastroianni, AC, Chen, WH, Macklin, R, “For Now, It’s Unethical to Use Human Challenge Studies for SARS-CoV-2 Vaccine Development,” Proceedings of the National Academy of Sciences, Oct 2020. DOI: https://doi.org/10.1073/pnas.2021189117.
- Ehmann MR, Zink EK, Levin AB, et al incl. Kahn J, “Operational Recommendations for Scarce Resource Allocation in a Public Health Crisis,” CHEST, 159 (3): 1076-1083; March 2021. DOI: https:// doi.org/10.1016/j.chest.2020.09.246.
- Kahn, JP, Mastroianni, AC, Venkatapuram, S. “Bioethics in a Post-COVID World: Time for Future- Facing Global Health Ethics,” in Brands, Hal and Francis J. Gavin, eds., COVID-19 and World Order: The Future of Conflict, Competition, and Cooperation, Chapter 6. Johns Hopkins University Press, 2020.
12. Galiatsatos P, Kachalia A, Belcher HME, Hughes MT, Kahn J, Rushton CH Suarez JI, Biddison LD, Golden SH. Health equity and distributive justice considerations in critical care resource allocation. Lancet Respiratory Medicine, 8 (8): 758-760; 2020. DOI: https://doi.org/10.1016/S2213- 2600(20)30277-0.